Where The Microbiome Industry Comes Together
Microbiome Connect is the world leading business focused summit for microbiome drug development. We accelerate pipeline development and enable commercialization of therapeutics by uniting strategic partners and platforming the latest R&D breakthroughs. This is your opportunity to unlock investment opportunities, understand regulatory landscapes, and streamline manufacturing in the APAC region.
Regulation
Develop your regulatory considerations through receiving consultation and guidance on live-biotherapeutic products across the APAC region. Ensure your drug development milestones obtain regulatory standard and shorten your pathway to market.
Investment
Asia is anticipating the largest growth across the microbiome industry with a greater proportion of engaged investors than any other region. This is your opportunity to meet capital leaders and hear how to make your innovation stand out from the crowd.
Product Development
Deep dive into the best practices for data strategy, technology implementation, clinical development, and manufacturing across multiple therapeutic areas. Receive case-study demonstrations on how pipeline advancements are operationalized.
2
full days of content
30
trailblazing speakers
200
industry leading experts
1-2-1
bookable meeting opportunities
AUDIENCE BREAKDOWN
-
Biotechs45%
-
Pharma & Investors15%
-
Academia25%
-
Service Providers25%
Our Trailblazing Speakers
From every part of the microbiome industry, our expert speakers will take to the stage to share what’s happening now in the world of microbiome – and what’s going to happen next.
Yosep Ji
Chief Executive Officer
HEM Pharma
GwangPyo Ko
Chief Executive Officer
KoBioLabs
Yeung-Hyen Kim
Chief Technology Officer
Liveome
Jisoo Pae
Chief Executive Officer
Genome & Company
Sabu Thomas
Director
Centre of Excellence in Microbiome, Govt. of Kerala (India)
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology
Christian Eberle
Chief Executive Officer
Bacthera
Jun Kunisawa
Director, Microbial Research Center
NIBIOHN
Laure Cahuzac
Head of Development
Bacthera
Sang Sun Yoon, Ph.D.
Chief Executive Officer
BioMe Inc.
Sin-Hyeog Im, Ph.D.
Chief Executive Officer
ImmunoBiome Inc.
Download the Agenda
"If being part of the Microbiome Therapeutics conversation is important to your research or business goals, this is the place to be." - List Labs
Our conference programme features the latest insights from the industry’s top companies and key thoughts-leaders, tackling the most pertinent issues and trends in the industry.
With two days of content, you’ll be able to tailor your perfect agenda to meet your specific business needs – allowing you & your team to gain the tangible intel you need to fast-track your product development over the next 12 months.
Yosep Ji
Chief Executive Officer
HEM Pharma
GwangPyo Ko
Chief Executive Officer
KoBioLabs
Yeung-Hyen Kim
Chief Technology Officer
Liveome
Jisoo Pae
Chief Executive Officer
Genome & Company
Sabu Thomas
Director
Centre of Excellence in Microbiome, Govt. of Kerala (India)
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology
Christian Eberle
Chief Executive Officer
Bacthera
Jun Kunisawa
Director, Microbial Research Center
NIBIOHN
Laure Cahuzac
Head of Development
Bacthera
Sang Sun Yoon, Ph.D.
Chief Executive Officer
BioMe Inc.
Prof. Youngjin Hong, Ph.D
CTO
CNCure Co., Ltd
Sin-Hyeog Im, Ph.D.
Chief Executive Officer
ImmunoBiome Inc.
Grace Park
Vice President of Research & Development
HelloBiome
Sam Costello
Chief Executive Officer
BiomeBank
Jian-Da Lin
Assistant Professor
National Taiwan University
Nikole Kimes
Chief Executive Officer
Siolta Therapeutics
2
full days of content
30
trailblazing speakers
200
industry leading experts
1-2-1
bookable meeting opportunities
Conference Packages
- Saturday, March 16, 2024 to Saturday, April 20, 2024Tier 1 - Academics$849Researchers working solely at an Academic Institute or Hospital
- Saturday, March 16, 2024 to Saturday, April 20, 2024Tier 2 - Drug Developers & Pharma$1,599Must have a publicly available active pipeline
- Saturday, March 16, 2024 to Saturday, April 20, 2024Tier 3 - Service Providers$3,499Including consultants, equipment manufacturers, platform technology and service provider companies
- Sunday, April 21, 2024 to Sunday, May 26, 2024Tier 1 - Academics$999Researchers working solely at an Academic Institute or Hospital
- Sunday, April 21, 2024 to Sunday, May 26, 2024Tier 2 - Drug Developers & Pharma$1,899Must have a publicly available active pipeline
- Sunday, April 21, 2024 to Sunday, May 26, 2024Tier 3 - Service Providers$3,499Including consultants, equipment manufacturers, platform technology and service provider companies
- Saturday, May 25, 2024 to Friday, June 21, 2024Tier 1 - Academics$1,199Researchers working solely at an Academic Institute or Hospital
- Saturday, May 25, 2024 to Friday, June 21, 2024Tier 2 - Drug Developers & Pharma$2,299Must have a publicly available active pipeline
- Saturday, May 25, 2024 to Friday, June 21, 2024Tier 3 - Service Providers$3,999Including consultants, equipment manufacturers, platform technology and service provider companies
Preparing registration...
New additions in 2021
1. A dedicated manufacturing stream.
Witness a showcase of solutions to scaling up your bacterial fermentation operation, highlighting the different culturing methodologies, along with discussions regarding commercialisation preparation!
2. Join the microbiome biomarker conversation.
We will hear from companies like Takeda, Merck, and the PRI to discuss the clinical future of the microbiome as a diagnostic and endpoint, as well as examining how the industry can and should develop standardised biomarkers.
3. From clinical to conference!
Find leading biotech’s, discussing their latest clinical updates, mechanistic data, experimental methods, and clinical trial design.
The Microbiome Connect Series Network
The Microbiome Connect Series Network
REGISTER YOUR INTEREST
Please fill in the form on the right for access to the PDF agenda for the 2nd Annual Microbiome Connect: Asia Congress
Highlights from the program include:
Wednesday, 19 Jun, 2024
09:00-09:30
Navigating Investment Challenges for Microbiome Drug Development: The Roadmap to Investment
- Introduction to the current microbiome investment landscape and what direction investment is heading in over the next few years.
- Highlighting what investors need to see from emerging companies, how are CSB evaluating companies.
- How should microbiome companies adapt to trends and what should data packages contain.
Sou Miyake, Director of Investment & Business Development, Corundum Systems Biology
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology
12:00-12:30
Using Pharmaceutical Meta-Analytical Screening (PMAS) for Personalized Microbiome Solution
- Considerations for live-biotherapeutic development and applicability: reviewing microbiota variation, biomarkers, and metabolites.
- Integrating a personalization approach to therapeutic discovery, linking clinical trial outcomes with in-vitro results obtained from the PMAS system.
- How to harness the metabolome to guide the next generation of live-biotherapeutics.
Yosep Ji, Chief Executive Officer, HEM Pharma
Yosep Ji
Chief Executive Officer
HEM Pharma
Download the Agenda
PRE-CLINICAL PROGRAM SHOWCASE
INFORMATION
Showcase your promising pre-clinical programs to a jury of industry leading experts within microbiome for your opportunity to secure a full proof-of concept study. The Microbiome Connect Pre-Clinical Program showcase is an opportunity for any LBP companies based in APAC to make the most of their conference attendance.
Three programs will be shortlisted by our jury to give a 10-minute presentation at the conference. With one overall winner announced who will receive a free full PoC study sponsored by Bacthera. The exact content of the PoC study is at Bacthera's sole discretion.
Deadlines for application: April 27 2023
Candidates announced: May 3 2023
Presentations: May 17 2023
Winner Announced: May 18 2023
COMPETITION PRIZE
The winning program will receive a full Drug Substance & Drug Product Proof of Concept Study sponsored by Bacthera during 2023/2024, based on Bacthera standard technologies (DS+DP):
- Including high-throughput screening
- Fermentation, drying, filling and testing of
- 1x 2x 10L batch
- Including 1-2 months stability study
2023 PRE-CLINICAL PROGRAM SHOWCASE COMPETITION JUDGES
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology
SeungHwan Lee
Associate Professor
Seoul National University Hospital
Sou Miyake
Director of Investment & Business Development
Corundum Systems Biology
SeungHwan Lee
Associate Professor
Seoul National University Hospital
POSTER SUBMISSIONS
Are you looking to showcase your recent work to the Microbiome community?
Our dedicated poster session is the perfect way to get your research noticed, ideal for PhD students or Post-Doctoral researchers.
Subject to successful registration, your presentation will be displayed in a dedicated poster area at the event. The poster presentation session time of taking place is to be confirmed.
SUBMISSION DEADLINE: 7PM (KST) FRIDAY MAY 5 2023
Abstracts received after this time may not be accepted so please submit your abstract as soon as possible! Academics that submit a poster abstract before May 5 get a $100 discount!
Posters should be one page PDF, sized A0 (841mm x 1189mm) in portrait orientation.
If you have any questions please contact [email protected]
Click HERE to make your submission before MAY 5.
FOUNDERS FORUM: CONNECT WITH INDUSTRY PEERS
Are you looking to grow your business network?
Looking ahead to 2023, you can join CEOs, Founders and Business Leaders to collaborate, brainstorm ideas, share pain-points and find solutions to the current challenges of launching and running a successful microbiome biotech today.
Get straight to the heart of the issues at the top of your priority list with other biotech leaders
Register below, and a member of the Microbiome Connect Team will be in touch.
If you have any questions please contact [email protected].
2024 SPONSORS
Headline Partner
Bacthera
Website: https://www.bacthera.com/
Bacthera is a Danish/Swiss-based one-stop CDMO in the field of LBP’s, with the overall goal to enable the entire industry to further flourish by introducing industry changing innovations.
From small start-up’s to globally operating pharmaceutical companies, we support our clients developing analytical and manufacturing processes of their strains. With our long experience in handling bacteria in DS and DP production, we can offer tailor-made development and large-scale commercial solutions. Within our facilities, we can handle:
- Strictly and facultative anaerobes
- BSL1/2 categorized strains
- GMO’s
Our customers benefit from background technologies and GMP manufacturing know-how that originate from our mother companies Chr. Hansen & Lonza. In addition, Bacthera’s process expertise, enabling innovations and our world-class analytical services will contribute to our customer’s successful development of their LBP.
Platinum Partner
Biose Industrie
Website: https://www.biose.com/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
Silver Partner
Exhibitor
Procelys by Lesaffre
Website: https://procelys.com/
At Procelys by Lesaffre, we address biotech challenges in biopharma, food & feed, and renewable industries via fermentation by feeding living microorganisms. We advise, design, produce, and market solutions adapted to customers’ challenges. Everyday, on the five continents, together with our partners, we create value while empowering them with natural, innovation, and performing solutions. We are Biotech Partners.
PARTNER WITH US
Microbiome Connect is your global, multi-channel partner to reach, engage and interact with the most influential and important stakeholders in the world of microbiome. With a solution to hit every objective, our high-level programmes, tailored introductions, bespoke networking and content-driven marketing offer multiple ways to engage your target market both at the event and in the run up.
Why partner with us?
- Be recognized as an industry leader
- Get the eyes of hundreds of decision makers on your brand
- Create space for the most important conversations, and the ones you never knew were out there
- Network with the microbiome industry elite
- Amplify your biggest announcements, research and expertise
PARTNER WITH US
Partner with Health Equity & SDoH Implementation for the most significant impact and visibility amongst senior health equity and clinical trial leaders.
Our sponsorship opportunities offer high-quality partnering and networking options alongside content sessions to showcase the latest developments and cutting-edge innovations to create an unrivalled platform to engage and inspire the industry.
Content our Partnerships Lead, Simon Pickles to get started.
Venue
854 Nonhyeon-ro, Gangnam-gu, Seoul 06022
Microbiome Connect invites you to join us at The Andaz Seoul Gangnam, June 19-20 2024.
For discounted rooms on June 18 and 19, please see here: Hyatt | Select Room
Testimonials
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
We'd love to hear from you.
Contact us at +44 (0)20 3696 2920 and email [email protected], or let us know what subject area you're interested in below.
